Back to search

Article

Initial ticagrelor monotherapy strategy is effective and safe in patient with high bleeding risk after percutaneous coronary intervention: series case reports and literature review

2022-10-05

Abstract excerpt

<h4>Objective: </h4> Short-term duration of dual antiplatelet therapy (DAPT) followed by ticagrelor monotherapy after percutaneous coronary intervention (PCI) among patients at high bleeding risk (HBR) was identified in numerous clinical trials, but the effect of ticagrelor monotherapy as an initial regimen was unknown. To explore the efficacy and safety of ticagrelor monotherapy after PCI in patient at HBR. Pati...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ab115ec4-fa0a-5900-bb2d-ed9c35995d78
DOI
10.21203/rs.3.rs-2051369/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Initial ticagrelor monotherapy strategy is effective and safe in patient with high bleeding risk after percutaneous coronary intervention: series case reports and literature reviewDOI 10.21203/rs.3.rs-2051369/v2
Ticagrelor versus clopidogrel in acute coronary syndrome patients with concurrent high ischemic and bleeding risk after drug-eluting stent implantationSemantic proximity
Dual antiplatelet therapy in patients with coronary artery disease after percutaneous coronary intervention with drug-eluting stents: A systematic review and network meta-analysisSemantic proximity
A Comparison of the Effects of Ticagrelor and Clopidogrel in Patients with Acute ST-Segment Elevation Myocardial Infarction: A systematic review and Meta-analysisSemantic proximity
Changes of antithrombotic prescription in atrial fibrillation patients with acute coronary syndrome or percutaneous coronary intervention and the subsequent impact on long-term outcomes: A longitudinal cohort studySemantic proximity
Effect of pharmacogenomics - oriented Dual Antiplatelet Therapy Followed by P2Y12 receptor inhibitors/Aspirin on Cardiovascular and Bleeding Events in ACS Patients: A Trial ProtocolSemantic proximity
Utilization of Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary InterventionSemantic proximity
Efficacy and safety of genotype-guided antiplatelet therapy versus standard treatment in 4,604 patients with CAD after PCI: a meta-analysis of randomized controlled trials.Semantic proximity
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry.Semantic proximity
Intravascular Imaging-Guided Versus Angiography-Guided PCI: Systematic Review and Meta-analysis of 24 Randomized Controlled TrialsSemantic proximity
Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based, ReviewSemantic proximity
Guided antiplatelet therapy with P2Y12 antagonists in patients undergoing percutaneous coronary intervention: 3 systematic reviews with meta-analyses of randomized controlled trials with homogeneous designSemantic proximity
Genotype-Guided Antiplatelet Therapy Versus Standard Therapy for Patients with Coronary Artery Disease: An Updated Systematic Review and Meta-Analysis.Semantic proximity
Select a neighboring publication to make it the new centre.